These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8050046)

  • 1. Blockade by 1,3-dipropyl-8-cyclopentylxanthine (CPX) of purine protection against kainate neurotoxicity.
    Macgregor DG; Stone TW
    Brain Res; 1994 May; 644(2):339-42. PubMed ID: 8050046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.
    MacGregor DG; Miller WJ; Stone TW
    Br J Pharmacol; 1993 Sep; 110(1):470-6. PubMed ID: 8220909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of kainate-induced excitotoxicity by a purine analogue.
    MacGregor DG; Stone TW
    Neuroreport; 1992 Jun; 3(6):536-8. PubMed ID: 1327268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic and saliuretic effects of 1,3-dipropyl-8-cyclopentylxanthine, a selective A1-adenosine receptor antagonist.
    Collis MG; Shaw G; Keddie JR
    J Pharm Pharmacol; 1991 Feb; 43(2):138-9. PubMed ID: 1672902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention by a purine analogue of kainate-induced neuropathology in rat hippocampus.
    MacGregor DG; Jones PA; Maxwell WL; Graham DI; Stone TW
    Brain Res; 1996 Jun; 725(1):115-20. PubMed ID: 8828594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic activity of adenosine receptor activation in mice.
    Jain N; Kemp N; Adeyemo O; Buchanan P; Stone TW
    Br J Pharmacol; 1995 Oct; 116(3):2127-33. PubMed ID: 8640355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P1-purinoceptors that mediate the prejunctional inhibitory effect of adenosine on capsaicin-sensitive nonadrenergic noncholinergic neurotransmission in the rat mesenteric arterial bed are of the A1 subtype.
    Rubino A; Ralevic V; Burnstock G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1100-4. PubMed ID: 8263771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The attenuation of kainate-induced neurotoxicity by chlormethiazole and its enhancement by dizocilpine, muscimol, and adenosine receptor agonists.
    MacGregor DG; Graham DI; Stone TW
    Exp Neurol; 1997 Nov; 148(1):110-23. PubMed ID: 9398454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration.
    MacGregor DG; Stone TW
    Br J Pharmacol; 1993 Jun; 109(2):316-21. PubMed ID: 8358536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
    Prentice DJ; Hourani SM
    Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by an adenosine analogue against kainate-induced extrahippocampal neuropathology.
    MacGregor DG; Graham DI; Jones PA; Stone TW
    Gen Pharmacol; 1998 Aug; 31(2):233-8. PubMed ID: 9688465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine suppression of proliferation of Sertoli-like TM4 cells in culture.
    Shaban M; Smith RA; Stone TW
    Cell Prolif; 1995 Dec; 28(12):673-82. PubMed ID: 8634374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro.
    Chesi AJ; Stone TW
    Exp Brain Res; 1997 Feb; 113(2):303-10. PubMed ID: 9063716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine inhibits norepinephrine release in the postischemic rat heart: the mechanism of neuronal stunning.
    Burgdorf C; Richardt D; Kurz T; Seyfarth M; Jain D; Katus HA; Richardt G
    Cardiovasc Res; 2001 Mar; 49(4):713-20. PubMed ID: 11230970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels.
    Plamondon H; Blondeau N; Heurteaux C; Lazdunski M
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1296-308. PubMed ID: 10598933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
    Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the aryl substituent kind and distance from pyrimido[2,1-f]purindiones on the adenosine receptor selectivity and antagonistic properties.
    Drabczyńska A; Schumacher B; Müller CE; Karolak-Wojciechowska J; Michalak B; Pekala E; Kieć-Kononowicz K
    Eur J Med Chem; 2003 Apr; 38(4):397-402. PubMed ID: 12750027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional characterization of A1 and A2 adenosine receptors in the rat vas deferens: a comparison with A1 receptors in guinea pig left atrium and A2 receptors in guinea pig aorta.
    Martin PL; May JM
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1228-35. PubMed ID: 8014866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of renal A(1) adenosine receptors in vivo.
    Lee HT; Cuomo-Scholer A; Belloni FL; Thompson CI
    Exp Nephrol; 2002; 10(1):43-50. PubMed ID: 11803204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement.
    Armstrong S; Ganote CE
    Cardiovasc Res; 1994 Jul; 28(7):1049-56. PubMed ID: 7525060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.